TE_38224
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE order | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 1231.92 |
| Counts of samples | TCGA_tumor:1092; TCGA_normal:0; GTEx:0 |
| TSS | chrX(-):149436201 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38224.31 | - | Intergenic | Non-coding | Non-coding | chrX(-):149364573,149364593,149366380,149366517,149436075,149436202 |
| teRNA_38224.32 | - | Intergenic | Non-coding | Non-coding | chrX(-):149364573,149364593,149366380,149366517,149376059,149376112,149378933,149379033,149379129,149379280,149400539,149400613,149436075,149436202 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
